Latest News

  • Aastrom Plans for the Next Step

    Aastrom, a cellular therapy company in Michigan, has finalized plans for a Phase III clinical study of Ixmyelocel-T as a treatment for Critical Limb Ischemia (CLI). CLI is the...

    • Posted 1 September, 2011
    • 0
  • Induced Direct Transdifferentiation Shows Promise

    Induced direct transdifferentiation (iT) results in the conversion of one mature cell type to another mature cell type. The procedure can convert cell phenotype across germ layers or within...

    • Posted 25 August, 2011
    • 0
  • A Possible Cure for the Flu…

    A cure for the flu is something we all wish for, right along with a cure for the common cold. Researchers have done well in providing a preventative seasonal...

    • Posted 23 August, 2011
    • 0
  • How to Solve the Most Pressing Biomanufacturing Challenges

    The Massachusetts Institute of Technology (MIT) recently published an article in Technology Review titled, “Why is Biomanufacturing so Hard?,” in which they discussed the challenges to biopharmaceutical manufacturing. The...

    • Posted 16 August, 2011
    • 0
  • Increase in Human Embryonic Stem Cell Research Helps Future of Industry

    Since President Obama repealed research restrictions on human embryonic stem cells (hESCs) in 2009, hESC research has expanded significantly. Before the repeal there were 20 hESC-endorsed lines available for...

    • Posted 11 August, 2011
    • 1